| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |